Filing Details
- Accession Number:
- 0001209191-20-007531
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-07 16:31:46
- Reporting Period:
- 2020-02-05
- Accepted Time:
- 2020-02-07 16:31:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1080709 | Arena Pharmaceuticals Inc | ARNA | Pharmaceutical Preparations (2834) | 232908305 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1612551 | Amit Munshi | C/O Arena Pharmaceuticals, Inc. 6154 Nancy Ridge Drive San Diego CA 92121 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-02-05 | 7,129 | $50.00 | 7,750 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person.